期刊
JOURNAL OF IMMUNOLOGY
卷 193, 期 6, 页码 2812-2820出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1401358
关键词
-
类别
资金
- Clinical and Translational Science Award program of the National Center for Research Resources [1UL1RR031973]
- American Cancer Society
- Medical College of Wisconsin Cancer Center
- National Institute of Allergy and Infectious Diseases Public Health Service research grants
- Strategic Basic Research Programs of the Japan Science and Technology Agency
TCR signal strength during priming is a key determinant of CD4 T cell activation, but its impact on effector CD4 T functions in vivo remains unclear. In this study, we compare the functionality of CD4 T cell responses induced by peptides displaying varying binding half-lives with MHC class II before and after influenza virus infection. Although significant quantitative and qualitative differences in CD4 T cell responses were observed before infection between mice vaccinated with low-or high-stability peptides, both mice mounted robust early Th1 effector cytokine responses upon influenza challenge. However, only effector CD4 T cells induced by low-stability peptides proliferated and produced IL-17A after influenza challenge. In contrast, effector T cells elicited by higher-stability peptides displayed a terminally differentiated phenotype and divided poorly. This defective proliferation was T cell intrinsic but could not be attributed to a reduced expression of lymph node homing receptors. Instead, we found that CD4 T cells stimulated with higher-stability peptides exhibited decreased responsiveness to low levels of Ag presentation. Our study reveals the critical role of TCR signal strength during priming for the function and Ag sensitivity of effector CD4 T cells during viral challenge.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据